Date: 2014-04-25
Type of information: Fundraising
Company: Genalice (The Netherlands)
Investors: Redbrae (UK-USA)
Amount: undisclosed
Funding type:
Planned used:
Others: * On April 25, 2014, Genalice has announced that it has reached an agreement on a multi-million euro capital investment from Redbrae, a consortium of US- and UK-based private equity investors. The investment consortium has a strong network in the United States, United Kingdom and Middle East. It has been working with Genalice for the past year. The successful validation and launch of GENALICE MAP, the company’s groundbreaking DNA data processing solution, formed the basis for the latest financial injection that will provide significant backing to accelerate further product development and distribution. Genalice is a data processing and storage solution, available immediately. It is already being evaluated and installed by high-volume NGS centers, institutes and companies around the world.
Therapeutic area:
